All News #Library
Biotech
Anaveon Names Thaminda Ramanayake CEO
23 Mar 2026 //
GLOBENEWSWIRE
Anaveon announces first patient dosed with ANV419 in a Ph I/II Study of ANV419
16 Mar 2023 //
GLOBENEWSWIRE
Anaveon doses first patient in a Phase I/II Study of ANV419 as monotherapy
02 Feb 2023 //
GLOBENEWSWIRE

Market Place
Sourcing Support